Will Merck & Co., Inc.(NYSE:MRK), TherapeuticsMD Inc(NYSEMKT:TXMD), and Zogenix, Inc.(NASDAQ:ZGNX) Come To Dominate The Drug Manufacturing Business?
New York, NY – GDP INSIDER – 10/17/2014.
This article discusses three drug manufacturers: Merck & Co., Inc.(NYSE:MRK), TherapeuticsMD Inc(NYSEMKT:TXMD), and Zogenix, Inc.(NASDAQ:ZGNX)
Merck & Co., Inc.(NYSE:MRK) is a New Jersey-based drug manufacturer that provides health solutions through its biologic therapies, prescription medicines, and vaccines. The company previously operated a consumer care business, but sold that portion of the company to Bayer AG for $14.2 billion on Oct. 1st, 2014. The company saw its trading volume spike to a figure of 21.9 million yesterday, a figure which is 12.9 million higher than the company’s three month average volume of 9.0 million.
TherapeuticsMD Inc(NYSEMKT:TXMD) currently has a bid price of $2.74 x 400 and an offer price of $4.39 x 10,000, figures which suggest that the company’s value may soon fluctuate in the future. The Florida-based company manufactures and distributes branded and generic prescription prenatal vitamins and over-the-counter vitamins and cosmetics. On Oct. 15th, the company announced that it would be presenting positive data on its studies of TX-004HR at the 25th Annual Meeting of The North American Menopause Society.
Zogenix, Inc.(NASDAQ:ZGNX) had a trading volume of 3.02 million yesterday, a figure which is 1.27 million higher than its three month average volume of 1.75 million. The California-bas drug manufacturer develops and commercializes treatments that are used to help patients with central nervous system disorders. The company submitted a version of the Zohydro painkiller to the United States FDA, emphasizing that this version of the drug was far harder to abuse than the currenty version.
HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.
Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.
Disclosure: HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.